Latest return on equity
Compass Therapeutics Return on equity
Direct answer
Compass Therapeutics's return on equity is -56.66%.
The verified market snapshot reports -56.66%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 19, 2026.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -56.66%
Explore related company data
View Compass Therapeutics's market capitalizationView Compass Therapeutics's price-to-book ratioView Compass Therapeutics's 52-week price rangeView Compass Therapeutics's profit marginView Compass Therapeutics's debt-to-equity ratioView all Compass Therapeutics key metricsReturn to Compass Therapeutics profile